Janssen Presenting New IBD Data from Gastroenterology Portfolio at Annual Meeting

Janssen Presenting New IBD Data from Gastroenterology Portfolio at Annual Meeting
Pennsylvania-based Janssen Biotech is presenting 15 abstracts at the 2016 Digestive Disease Week (DDW) annual meeting May 21-24 in San Diego, California. Presentations will include data from the Janssen gastroenterology portfolio of injection and infusion biologic therapies, primarily results from the pivotal Phase 3 (IM-UNITI) Stelara (ustekinumab) maintenance therapy study for adults with moderate to severe Crohn’s disease; results of an

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *